Switzerland · Delayed Price · Currency is CHF Medacta Group Statistics
Total Valuation
Medacta Group has a market cap or net worth of CHF 2.27 billion. The enterprise value is 2.53 billion.
| Market Cap | 2.27B |
| Enterprise Value | 2.53B |
Important Dates
The last earnings date was Wednesday, September 9, 2026.
| Earnings Date | Sep 9, 2026 |
| Ex-Dividend Date | May 7, 2026 |
Share Statistics
Medacta Group has 19.95 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 19.95M |
| Shares Outstanding | 19.95M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 69.75% |
| Owned by Institutions (%) | 7.75% |
| Float | 6.03M |
Valuation Ratios
The trailing PE ratio is 31.79 and the forward PE ratio is 21.40.
| PE Ratio | 31.79 |
| Forward PE | 21.40 |
| PS Ratio | 3.47 |
| PB Ratio | 5.08 |
| P/TBV Ratio | 5.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 18.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.44 |
| EV / Sales | 3.87 |
| EV / EBITDA | 15.22 |
| EV / EBIT | 25.48 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.10 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | -181.22 |
| Interest Coverage | 18.70 |
Financial Efficiency
Return on equity (ROE) is 17.03% and return on invested capital (ROIC) is 11.05%.
| Return on Equity (ROE) | 17.03% |
| Return on Assets (ROA) | 7.19% |
| Return on Invested Capital (ROIC) | 11.05% |
| Return on Capital Employed (ROCE) | 13.93% |
| Weighted Average Cost of Capital (WACC) | 8.66% |
| Revenue Per Employee | 287,473 |
| Profits Per Employee | 31,386 |
| Employee Count | 2,036 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 0.86 |
Taxes
In the past 12 months, Medacta Group has paid 19.10 million in taxes.
| Income Tax | 19.10M |
| Effective Tax Rate | 21.11% |
Stock Price Statistics
The stock price has decreased by -24.67% in the last 52 weeks. The beta is 0.97, so Medacta Group's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -24.67% |
| 50-Day Moving Average | 130.96 |
| 200-Day Moving Average | 145.88 |
| Relative Strength Index (RSI) | 21.49 |
| Average Volume (20 Days) | 28,159 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medacta Group had revenue of CHF 653.43 million and earned 71.34 million in profits. Earnings per share was 3.57.
| Revenue | 653.43M |
| Gross Profit | 428.06M |
| Operating Income | 99.23M |
| Pretax Income | 90.44M |
| Net Income | 71.34M |
| EBITDA | 157.42M |
| EBIT | 99.23M |
| Earnings Per Share (EPS) | 3.57 |
Balance Sheet
The company has 33.22 million in cash and 295.94 million in debt, with a net cash position of -262.71 million or -13.17 per share.
| Cash & Cash Equivalents | 33.22M |
| Total Debt | 295.94M |
| Net Cash | -262.71M |
| Net Cash Per Share | -13.17 |
| Equity (Book Value) | 445.99M |
| Book Value Per Share | 22.36 |
| Working Capital | 240.19M |
Cash Flow
In the last 12 months, operating cash flow was 124.99 million and capital expenditures -126.62 million, giving a free cash flow of -1.63 million.
| Operating Cash Flow | 124.99M |
| Capital Expenditures | -126.62M |
| Depreciation & Amortization | 59.73M |
| Net Borrowing | 38.92M |
| Free Cash Flow | -1.63M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 65.51%, with operating and profit margins of 15.19% and 10.92%.
| Gross Margin | 65.51% |
| Operating Margin | 15.19% |
| Pretax Margin | 13.84% |
| Profit Margin | 10.92% |
| EBITDA Margin | 24.09% |
| EBIT Margin | 15.19% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.88%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 0.88% |
| Dividend Growth (YoY) | 59.42% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 31.05% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 0.82% |
| Earnings Yield | 3.15% |
| FCF Yield | -0.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Medacta Group is 178.05, which is 56.73% higher than the current price. The consensus rating is "Buy".
| Price Target | 178.05 |
| Price Target Difference | 56.73% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 10.96% |
| EPS Growth Forecast (3Y) | 15.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medacta Group has an Altman Z-Score of 5.67 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.67 |
| Piotroski F-Score | 4 |